What is UltraGreen?
UltraGreen operates at the intersection of advanced medical technology and enterprise-grade data management. The company provides a sophisticated AI-driven platform designed to synthesize complex clinical datasets into actionable insights, thereby enhancing decision-making processes for healthcare providers and research institutions. By streamlining data workflows and improving diagnostic accuracy, UltraGreen addresses the critical need for interoperability and intelligence in modern healthcare systems. Its market position is defined by its ability to bridge the gap between raw medical data and clinical utility, making it an essential partner for organizations navigating the complexities of digital health transformation.
How much funding has UltraGreen raised?
UltraGreen has raised a total of $188M across 1 funding round:
Other Financing Round
$188M
Other Financing Round (2025): $188M with participation from 65 Equity Partners, Vitruvian Partners, and August Global Partners
Key Investors in UltraGreen
65 Equity Partners
65 Equity Partners is a global investment firm that partners with founders to create sustainable long-term value, focusing on family-owned and entrepreneur-led businesses in Southeast Asia, Europe, and the United States.
Vitruvian Partners
Vitruvian Partners is a European private equity firm focusing on leveraged buyout and growth capital investments in middle-market companies across the UK, Europe, and emerging markets.
August Global Partners
August Global Partners is a growth-oriented fund management company based in Singapore, specializing in healthcare investments ranging from venture to growth-stage, with a focus on AI-powered health technologies.
What's next for UltraGreen?
Looking ahead, the strategic deployment of the $188M will likely focus on expanding UltraGreen's presence in key international markets and enhancing its AI-driven analytical capabilities. The company is expected to prioritize the integration of its platform with existing hospital information systems, further embedding its technology into the standard clinical workflow. Furthermore, the backing from major institutional investors suggests a clear trajectory toward long-term value creation, potentially involving strategic acquisitions or the development of new, specialized modules for precision medicine. As the firm scales, its focus will remain on maintaining data integrity while driving the next wave of healthcare innovation through scalable, intelligent software solutions.
See full UltraGreen company page
